DK496687A - Anvendelse af medetomidin til fremstilling af laegemiddel til brug ved behandling af angstsygdomme - Google Patents

Anvendelse af medetomidin til fremstilling af laegemiddel til brug ved behandling af angstsygdomme

Info

Publication number
DK496687A
DK496687A DK496687A DK496687A DK496687A DK 496687 A DK496687 A DK 496687A DK 496687 A DK496687 A DK 496687A DK 496687 A DK496687 A DK 496687A DK 496687 A DK496687 A DK 496687A
Authority
DK
Denmark
Prior art keywords
treatment
medetomidin
diseases
preparation
application
Prior art date
Application number
DK496687A
Other languages
English (en)
Other versions
DK496687D0 (da
DK175040B1 (da
Inventor
Risto Lammintausta
Raimo Virtanen
Original Assignee
Farmos Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Farmos Oy filed Critical Farmos Oy
Publication of DK496687D0 publication Critical patent/DK496687D0/da
Publication of DK496687A publication Critical patent/DK496687A/da
Application granted granted Critical
Publication of DK175040B1 publication Critical patent/DK175040B1/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Saccharide Compounds (AREA)
DK198704966A 1986-11-11 1987-09-22 Anvendelse af medetomidin til fremstilling af lægemiddel til brug ved behandling af angstsygdomme DK175040B1 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FI864570A FI864570A0 (fi) 1986-11-11 1986-11-11 Terapeutiskt anvaendbar foerening.
FI864570 1986-11-11

Publications (3)

Publication Number Publication Date
DK496687D0 DK496687D0 (da) 1987-09-22
DK496687A true DK496687A (da) 1988-05-12
DK175040B1 DK175040B1 (da) 2004-05-10

Family

ID=8523472

Family Applications (1)

Application Number Title Priority Date Filing Date
DK198704966A DK175040B1 (da) 1986-11-11 1987-09-22 Anvendelse af medetomidin til fremstilling af lægemiddel til brug ved behandling af angstsygdomme

Country Status (12)

Country Link
US (1) US4783477A (da)
EP (1) EP0270267B1 (da)
JP (1) JPS63135330A (da)
AT (1) ATE88343T1 (da)
AU (1) AU587144B2 (da)
DE (1) DE3785549T2 (da)
DK (1) DK175040B1 (da)
ES (1) ES2054687T3 (da)
FI (1) FI864570A0 (da)
HU (1) HU201472B (da)
IE (1) IE60121B1 (da)
ZA (1) ZA878055B (da)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2215206B (en) * 1988-02-29 1991-07-03 Farmos Oy 4-substituted imidazole derivatives useful in perioperative care
US5344840A (en) * 1988-02-29 1994-09-06 Orion-Yhtyma Oy 4-substituted imidazole derivatives useful in perioperative care
US5124157A (en) 1989-08-18 1992-06-23 Cygnus Therapeutic Systems Method and device for administering dexmedetomidine transdermally
GB2256135B (en) 1991-05-31 1995-01-18 Orion Yhtymae Oy Transdermal administration of 4-substituted imidazoles
GB9111732D0 (en) 1991-05-31 1991-07-24 Orion Yhtymae Oy The use of certain salts of medetomidine and its optically active enantiomers to regulate the rate of transdermal administration of the drugs
US5457100A (en) * 1991-12-02 1995-10-10 Daniel; David G. Method for treatment of recurrent paroxysmal neuropsychiatric
PT1036065E (pt) * 1997-12-04 2004-09-30 Allergan Inc Derivados de imidazol substituidos com actividade do tipo agonista nos receptores alfa 2b ou 2b/2c adrenergicos
US7795263B2 (en) * 2008-07-08 2010-09-14 Wildlife Laboratories, Inc. Pharmaceutical combination for and method of anesthetizing and immobilizing non-domesticated mammals
MX368880B (es) * 2012-10-15 2019-10-21 Orion Corp Dexmedetomidina y medetomidina para su uso en el alivio de la aversión al ruido en un animal.
KR101891185B1 (ko) 2013-10-07 2018-08-24 테이코쿠 팔마 유에스에이, 인코포레이티드 비진정량의 덱스메데토미딘의 경피 전달을 위한 방법 및 조성물
RU2646512C2 (ru) 2013-10-07 2018-03-05 ТЕЙКОКУ ФАРМА ЮЭсЭй, ИНК. Устройства для трансдермальной доставки дексмедетомидина и способы их применения
TWI709417B (zh) 2013-10-07 2020-11-11 美商帝國製藥美國股份有限公司 使用右美托咪啶經皮組成物用於治療注意力不足過動症、焦慮及失眠的方法及組成物
KR20190060007A (ko) 2016-10-31 2019-05-31 테이코쿠 팔마 유에스에이, 인코포레이티드 덱스메데토미딘 경피 전달 장치를 이용한 통증을 관리하는 방법
CN110072524A (zh) * 2016-12-13 2019-07-30 奥赖恩公司 用于治疗狗的分离焦虑的右美托咪定或美托咪定

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1560271A (en) * 1977-01-14 1980-02-06 Joullie International Sa Therapeutically useful m-trifluoromethylphenylpiperazine derivatives
US4147872A (en) * 1977-09-13 1979-04-03 Pfizer Inc. 3-[2-Hydroxy-4-(substituted)-phenyl]azacycloalkanes and derivatives thereof as analgesic agents and intermediates therefor
ZA815327B (en) * 1980-08-05 1982-07-28 Hoffmann La Roche Benzazepine derivatives
GB2101114B (en) * 1981-07-10 1985-05-22 Farmos Group Ltd Substituted imidazole derivatives and their preparation and use
US4575510A (en) * 1983-02-17 1986-03-11 Merrell Dow Pharmaceuticals Inc. Method of alleviating withdrawal symptoms
NZ208554A (en) * 1983-06-23 1987-06-30 American Cyanamid Co (aryl and heteroaryl)-(7-(aryl and heteroaryl)-pyrazolo (1,5-a) pyrimidin-3-yl)-methanone derivatives and pharmaceutical compositions
FI844786A0 (fi) * 1984-12-04 1984-12-04 Farmos Oy Terapeutiskt utnyttjbar foerening.
NL8500047A (nl) * 1985-01-09 1986-08-01 Philips Nv Televisie ontvanger met teletext-decodeerschakeling en paginanummergeheugen.

Also Published As

Publication number Publication date
DE3785549T2 (de) 1993-09-09
DK496687D0 (da) 1987-09-22
US4783477A (en) 1988-11-08
EP0270267A3 (en) 1990-07-04
DK175040B1 (da) 2004-05-10
ZA878055B (en) 1988-04-26
HU201472B (en) 1990-11-28
IE873015L (en) 1988-05-11
ES2054687T3 (es) 1994-08-16
EP0270267B1 (en) 1993-04-21
ATE88343T1 (de) 1993-05-15
EP0270267A2 (en) 1988-06-08
IE60121B1 (en) 1994-06-01
HUT45399A (en) 1988-07-28
JPS63135330A (ja) 1988-06-07
FI864570A0 (fi) 1986-11-11
AU7826987A (en) 1988-05-12
AU587144B2 (en) 1989-08-03
DE3785549D1 (de) 1993-05-27

Similar Documents

Publication Publication Date Title
IT8767624A0 (it) Dispositivo per il massaggio manuale del rivestimento cutaneo
IT8147668A0 (it) Dispositivo terapeutico per il trattamento di difficolta' nelle articolazioni in particolare nelle mani
IT7950379A0 (it) Procedimento per il trattamento di acque di scarico
DK496687D0 (da) Anvendelse af medetomidin til fremstilling af laegemiddel til brug ved behandling af angstsygdomme
IT8149325A0 (it) Procedimento per il trattamento dimateriali di rifiuto
ATE158183T1 (de) Arzneimittel zur behandlung von anxietas
FR2565493B1 (fr) Appareil d'electrotherapie, pour le traitement du cuir chevelu
FI891986A7 (fi) Farmaseuttiset koostumukset psoriasiksen hoitoon
DK472688A (da) Anvendelse af bezafibrat til behandling af diabetes
DK253688D0 (da) Laegemiddel til brug ved behandling af atherosclerose
DK162121C (da) Fremgangsmaade til behandling af affaldsprodukter
LV10391A (lv) Alkilfosforskabes savienojumu izmantosana psoriazes tipa slimibu arstesanai
FI844645L (fi) 1,7-difenyl-3-metylaza-7-cyan-8 -metyl-nonan foer anvaendning vid bekaempning av sjukdomar.
DK484186A (da) Fremgangsmaade til fremstilling af et praeparat til behandling af psoriasis
NO862454D0 (no) Fremgangsmaate for behandling av peroxydblekeavluter.
FR2585561B1 (fr) Appareil d'abduction des membres superieurs
FR2590479B2 (fr) Appareil d'abduction des membres superieurs
FR2601955B1 (fr) Procede de preparation d'alkyl et d'arylchlorosilane
FR2589064B1 (fr) Sterilisateur pour aiguilles d'acupuncture
BE894776A (fr) Composition sous forme de shampooing a base d'anthraline ou d'un derive pour le traitement des maladies de la peau
NO167677C (no) Fremgangsmaate ved behandling av stoepejernsmelter med magnesium
DE3684825D1 (de) Verwendung von n-(1-allyl-2-pyrrolidinylmethyl)-2-methoxy-4-amino-5-methylsulfamoylbenzamid zur behandlung der parkinson-krankheit.
RO94514A2 (ro) Procedeu pentru tratarea namolurilor
FI893001A7 (fi) Menetelmä uusien, terapeuttisesti käyttökelpoisten 1,2-bentsisoksatsol-3-yyli- ja 1,2-bentsisotiatsol-3-yylijohdannaisten valmistamiseksi
RO92740A2 (ro) Compozitie medicamentoasa pentru tratamentul otitelor

Legal Events

Date Code Title Description
PUP Patent expired